Anokion

Ecublens, Switzerland

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

$35.0M raised

Oct 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Anokion raised?

Anokion has raised $35.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.

Who are Anokion's investors?

Anokion's investors include Versant Ventures, Novartis Venture Fund, Celgene, Novo Ventures, Foundation for Innovation and Technology (FIT).

Where is Anokion headquartered?

Anokion is headquartered in Ecublens, Switzerland.

What does Anokion do?

Anokion is harnessing the power of natural immune equilibrium to develop solutions for antigen-specific immune tolerance.

What stage is Anokion at?

Anokion is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 18, 2022.

MLA

"Anokion — Funding & Investors." VCBacked, October 18, 2022, https://www.vcbacked.co/company/anokion. Accessed July 2, 2026.

APA

VCBacked. (2022). Anokion — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/anokion

Wikipedia (cite web)

{{cite web |title=Anokion — Funding & Investors |url=https://www.vcbacked.co/company/anokion |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 18, 2022.